Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Antimicrob Resist Infect Control. 2022 Jun 2;11(1):78. doi: 10.1186/s13756-022-01106-x.
When people who recently travelled abroad are admitted to a hospital back home, there is a risk of introducing highly resistant microorganisms (HRMO) into the hospital. To minimize this risk, a feasible infection prevention strategy should be developed. In this study, we investigated patients' travel history and behavior during travel and analyzed whether this was correlated to HRMO carriage at admission.
From May 2018 until August 2019, adult patients admitted to a large tertiary care center in the Netherlands were asked upon hospital admission to participate in the study. Included patients received a questionnaire about risk perception, travel history in the last year, and behavior during travel, and were screened for HRMO carriage at admission using a perianal swab.
Six hundred and eight questionnaires were handed out, of which 247 were returned (40.6%). One hundred and thirty (52.6%) patients did not travel abroad in the last year, of whom eight (6.2%) were HRMO carrier at admission. One hundred seventeen (47.4%) patients travelled in the preceding year, of whom seven patients (6.0%) were HRMO carrier at admission. Thirty patients (12%) travelled outside of Europe; in this group HRMO prevalence was 13.3% (4 out of 30). The majority of patients (71.3%) were aware that international travel could lead to carriage of HRMO, and an even larger majority (89.5%) would support a screening strategy upon hospital admission in case of a travel history, to minimize the risk of introducing HRMO.
We identified that half of admitted patients to a large tertiary care hospital travelled abroad in the last year, with only a small percentage outside Europe. We discuss several screening strategies and propose a strategy of screening and preemptive isolation of patients who travelled to Asia or Africa in the 2 months before their hospital admission; a strategy that patients would support.
当近期有出国旅行史的人被送回国内的医院时,他们有可能将高度耐药微生物(HRMO)带入医院。为了最大限度地降低这种风险,应制定可行的感染预防策略。在本研究中,我们调查了患者在旅行期间的旅行史和行为,并分析了这些因素与入院时 HRMO 携带情况是否相关。
从 2018 年 5 月至 2019 年 8 月,荷兰一家大型三级保健中心在入院时要求成年患者参与该研究。纳入的患者收到一份关于风险认知、过去一年的旅行史和旅行期间行为的问卷,并通过肛周拭子筛查 HRMO 携带情况。
共发放了 608 份问卷,其中 247 份被收回(40.6%)。130 名(52.6%)患者在过去一年中没有出国旅行,其中 8 名(6.2%)患者在入院时为 HRMO 携带者。117 名(47.4%)患者在过去一年中旅行过,其中 7 名(6.0%)患者在入院时为 HRMO 携带者。30 名(12%)患者前往欧洲以外的地区旅行;在该组中,HRMO 的流行率为 13.3%(30 名患者中有 4 名)。大多数(71.3%)患者意识到国际旅行可能导致 HRMO 的携带,更大比例(89.5%)的患者会支持在有旅行史的情况下在入院时进行筛查策略,以最大程度地降低引入 HRMO 的风险。
我们发现,在一家大型三级保健医院入院的患者中,有一半在过去一年中有出国旅行史,只有一小部分患者前往欧洲以外的地区旅行。我们讨论了几种筛查策略,并提出了一种筛查策略和对在入院前 2 个月前往亚洲或非洲旅行的患者进行抢先隔离的策略;该策略得到了患者的支持。